2.1 Continuous abstinence at post‐treatment |
1 |
286 |
Risk Ratio (M‐H, Random, 95% CI) |
0.80 [0.45, 1.44] |
2.2 Continuous abstinence at follow‐up |
1 |
286 |
Risk Ratio (M‐H, Random, 95% CI) |
0.57 [0.28, 1.16] |
2.3 Percentage days with substance use at post‐treatment |
5 |
523 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.21 [‐0.45, 0.03] |
2.4 Percentage days with substance use at follow‐up |
3 |
409 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.39 [‐0.96, 0.17] |
2.5 Consumed amount at post‐treatment |
1 |
25 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.42 [‐1.23, 0.39] |
2.6 Craving intensity at post‐treatment |
9 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.7 Craving intensity at follow‐up |
4 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.8 Treatment acceptability (attrition) |
14 |
1531 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.89, 1.26] |
2.9 Treatment acceptability (attrition): sensitivity analysis (fixed effects model) |
14 |
1531 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.07 [0.91, 1.25] |